KR890001548B1 - A process for preparing spiro-imidazolidines - Google Patents

A process for preparing spiro-imidazolidines

Info

Publication number
KR890001548B1
KR890001548B1 KR8604182A KR860004182A KR890001548B1 KR 890001548 B1 KR890001548 B1 KR 890001548B1 KR 8604182 A KR8604182 A KR 8604182A KR 860004182 A KR860004182 A KR 860004182A KR 890001548 B1 KR890001548 B1 KR 890001548B1
Authority
KR
South Korea
Prior art keywords
imidazolidines
spiro
preparing spiro
new
preparing
Prior art date
Application number
KR8604182A
Other languages
English (en)
Other versions
KR860008984A (ko
Inventor
Christopher A Lipinski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of KR860008984A publication Critical patent/KR860008984A/ko
Application granted granted Critical
Publication of KR890001548B1 publication Critical patent/KR890001548B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
KR8604182A 1985-05-29 1986-05-28 A process for preparing spiro-imidazolidines KR890001548B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US738,924 1985-05-29
US06/738,924 US4575507A (en) 1985-05-29 1985-05-29 Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use

Publications (2)

Publication Number Publication Date
KR860008984A KR860008984A (ko) 1986-12-19
KR890001548B1 true KR890001548B1 (en) 1989-05-08

Family

ID=24970055

Family Applications (1)

Application Number Title Priority Date Filing Date
KR8604182A KR890001548B1 (en) 1985-05-29 1986-05-28 A process for preparing spiro-imidazolidines

Country Status (21)

Country Link
US (1) US4575507A (ko)
EP (1) EP0203791B1 (ko)
JP (1) JPS61277671A (ko)
KR (1) KR890001548B1 (ko)
AT (1) ATE46332T1 (ko)
AU (1) AU560429B2 (ko)
DD (5) DD264213A5 (ko)
DE (1) DE3665584D1 (ko)
DK (1) DK248886A (ko)
EG (1) EG17859A (ko)
ES (2) ES8800228A1 (ko)
FI (1) FI862251A (ko)
GR (1) GR861388B (ko)
HU (4) HU196060B (ko)
IL (1) IL78954A (ko)
NO (1) NO862123L (ko)
NZ (1) NZ216334A (ko)
PH (1) PH22213A (ko)
PL (5) PL147400B1 (ko)
PT (1) PT82650B (ko)
ZA (1) ZA863934B (ko)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4680306A (en) * 1984-07-20 1987-07-14 Pfizer Inc. Sprio-imidazolones for treatment of diabetes complications
US4762839A (en) * 1985-06-06 1988-08-09 Tanabe Seiyaku Co., Ltd. Quinazolinone copmpounds useful for the prophyloxis and treatment of diabetic complications
JPS63132889A (ja) * 1986-11-21 1988-06-04 Tanabe Seiyaku Co Ltd キナゾリノン誘導体
WO1988006887A1 (en) * 1987-03-20 1988-09-22 Alcon Laboratories, Inc. Use of aldose reductase inhibitors to enhance insulin sensitivity in diabetes mellitus
US5202339A (en) * 1987-08-28 1993-04-13 Mochida Pharmaceutical Co., Ltd. Hydantoin derivatives
US5004751A (en) * 1987-08-28 1991-04-02 Mochida Pharmaceutical Co., Ltd. Hydantoin derivatives
WO1990002126A1 (en) * 1988-08-24 1990-03-08 Mochida Pharmaceutical Co., Ltd. Hydantoin derivatives
US5068332A (en) * 1990-10-12 1991-11-26 American Home Products Corporation Alkylidene analogs of 1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones useful as aldose reductase inhibitors
US8326636B2 (en) * 2008-01-16 2012-12-04 Canyon Ip Holdings Llc Using a physical phenomenon detector to control operation of a speech recognition engine
CN104080775A (zh) * 2012-02-09 2014-10-01 勃林格殷格翰国际有限公司 立体选择性合成1,4-保护的9-羟基-5-氧代-1,4-二氮杂-螺[5.5]十一烷的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4117230A (en) 1976-10-18 1978-09-26 Pfizer Inc. Hydantoin derivatives as therapeutic agents
CA1088945A (en) * 1976-10-18 1980-11-04 Pfizer Limited Hydantoin derivatives as therapeutic agents
US4235911A (en) * 1979-06-13 1980-11-25 Pfizer Inc. Hydantoin derivatives
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation
ATE23046T1 (de) * 1982-11-10 1986-11-15 Pfizer Sorbinil durch optische aufspaltung mit aminopinanderivaten.
ZA839023B (en) * 1982-12-06 1985-07-31 Pfizer Spiro-3-hetero-azolones for treatment of diabetic complications
US4556670A (en) 1982-12-06 1985-12-03 Pfizer Inc. Spiro-3-hetero-azolones for treatment of diabetic complications
DE3561198D1 (en) * 1984-03-23 1988-01-28 Pfizer Spiro-indenes and spiro-1,2-dihydro-naphthalenes for treatment of diabetic complications
US4762838A (en) 1985-08-30 1988-08-09 Pfizer Inc. Quinazolin-4(3H)-one derivatives as anticoccidial agents

Also Published As

Publication number Publication date
PL266365A1 (en) 1988-03-03
EP0203791A1 (en) 1986-12-03
ES8801830A1 (es) 1988-02-16
AU560429B2 (en) 1987-04-09
JPS61277671A (ja) 1986-12-08
HU893127D0 (en) 1990-01-28
ES555375A0 (es) 1987-11-01
HU199845B (en) 1990-03-28
NO862123L (no) 1986-12-01
ES557391A0 (es) 1988-02-16
ZA863934B (en) 1988-01-27
FI862251A (fi) 1986-11-30
EG17859A (en) 1991-11-30
PL147399B1 (en) 1989-05-31
PL147400B1 (en) 1989-05-31
AU5801286A (en) 1987-01-08
DD264213A5 (de) 1989-01-25
ES8800228A1 (es) 1987-11-01
PL266364A1 (en) 1988-03-03
HUT44767A (en) 1988-04-28
NZ216334A (en) 1988-08-30
FI862251A0 (fi) 1986-05-28
DD264214A5 (de) 1989-01-25
DK248886A (da) 1986-11-30
EP0203791B1 (en) 1989-09-13
KR860008984A (ko) 1986-12-19
ATE46332T1 (de) 1989-09-15
PT82650A (en) 1986-06-01
PL266366A1 (en) 1988-03-03
DD273258A5 (de) 1989-11-08
PL146020B1 (en) 1988-12-31
HUT49882A (en) 1989-11-28
PL147397B1 (en) 1989-05-31
HU196060B (en) 1988-09-28
DK248886D0 (da) 1986-05-28
GR861388B (en) 1986-09-17
PH22213A (en) 1988-06-28
PL147398B1 (en) 1989-05-31
DD264215A5 (de) 1989-01-25
DD251972A5 (de) 1987-12-02
IL78954A (en) 1989-09-28
IL78954A0 (en) 1986-09-30
PL266363A1 (en) 1988-03-03
US4575507A (en) 1986-03-11
HUT49879A (en) 1989-11-28
DE3665584D1 (de) 1989-10-19
PT82650B (pt) 1988-11-30

Similar Documents

Publication Publication Date Title
NO2002009I2 (no) Tiotropium
KR890001548B1 (en) A process for preparing spiro-imidazolidines
MY108261A (en) Water soluble camptothecin derivatives
YU69289A (en) Substituted flavonoidic compounds, their salts and process for producing thereof
ATE108787T1 (de) Nervenschützende 3-piperidino-4- hydroxychromanderivate.
IL89807A (en) Topical preparation containing ofloxacin for treating otopathy
HUT56492A (en) Process for producing 3-arylcarbonyl-1-aminoalkyl-1h-indole derivatives and pharamceutical compositions comprising such compounds, against glaucoma
FI912892A0 (fi) Foerfarande foer framstaellning av substituerade och osubstituerade 2,3-pyridindikarboxylater ur klormaleat eller klorfumarat eller blandningar av dessa.
JPS6469677A (en) Curing catalyst for cationic electrodeposition paint
FI883812A0 (fi) 4'-deshydroxiepipodofyllotoxin -glukosider, syntes och anvaendning.
EP0446921A3 (en) Optically active alkylene-dioxybenzene derivatives and their use in therapy
IE850136L (en) Hydantoin derivatives
EP0432841A3 (en) Spiro-indoline-oxazine compounds with photochromatic and photosensitizing characteristics and the process for their preparation
DE59009525D1 (de) Herstellung von Isochinolinderivaten.
DE69011377D1 (de) Behandlung von alkoholischen Getränken.
HUT45250A (en) Process for producing 5-substituted octahydro-indolysin derivatives and pharmaceutical compositions containing them as active components
DE68911067D1 (de) Platin-(II)-diamin-Komplex, Verfahren zur Herstellung dieser Verbindung, Zusammensetzung mit Antitumorwirkung, die mindestens eine Platin-Verbindung enthält, und geformte Zusammensetzung mit Antitumorwirkung.
JPS55139333A (en) Spiro compound
SU1681502A1 (ru) Гидрохлорид 3-(2,5- диметоксибензоил) -4- диметиламинометил -5-окси-6- бромбензофурана, обладающий анальгетическим, местноанестезирующим, противосудорожным, противоаритмическим, стимулирующим коронарный, мозговой и почечный кровоток действиями
ES480561A1 (es) Un nuevo procedimiento para la preparacion de un compuesto vincadimero.
ATE25257T1 (de) 3-(2-(azabicyclo)ethyl)1,2,3,4-tetrahydro-5h(1)benzopyran(3,4-c)pyridin-5-one, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung.
HUT57227A (en) 2'-dezamino-4'-desoxy-4'-amino-8-fluoro-anthracycline derivatives, process for producing them as well as pharmaceutical preparatives containing said compounds as active substance
AU581101B2 (en) Anti-tumour platinum complexes, their preparation and their use
ES8703847A1 (es) Procedimiento para la obtencion de derivados de sulfonilgua-nidinopirimidina
JPS5283532A (en) Novel aromatic compounds

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee